Wave Life Sciences (WVE) Other Working Capital Changes (2017 - 2026)

Wave Life Sciences (WVE) has 11 years of Other Working Capital Changes data on file, last reported at -$1.4 million in Q2 2026.

• Quarterly Other Working Capital Changes rose 80.44% year-over-year to -$1.4 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$33.2 million (up 63.47% YoY) and the FY2025 annual result came in at -$19.8 million, up 78.81% from the prior year.
• Other Working Capital Changes climbed to -$1.4 million in Q2 2026, from -$28.2 million in the prior quarter.
• In the past five years, Other Working Capital Changes ranged from a high of $1.8 million in Q1 2023 to a low of -$4.3 million in Q2 2023.
• A 5-year average of -$1.6 million and a median of -$1.7 million in 2024 frame the typical range for Other Working Capital Changes.
• The widest YoY moves for Other Working Capital Changes: up 8082.83% in 2023, down 27742.38% in 2023.
• Tracing WVE's Other Working Capital Changes over 5 years: stood at -$1.2 million in 2022, then slumped by 543.34% to -$8.0 million in 2023, then tumbled by 932.82% to -$82.3 million in 2024, then surged by 92.75% to -$6.0 million in 2025, then soared by 76.79% to -$1.4 million in 2026.
• The last three Other Working Capital Changes figures came in at -$1.4 million (Q2 2026), -$28.2 million (Q1 2026), and -$6.0 million (Q4 2025), per Business Quant data.